DAA898 |
Sodium conservation decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA888 |
Glomeruli number decreases |
Physiological |
glomerulus |
Human |
— |
— |
|
DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA889 |
Glomeruli crowd together |
Physiological |
glomerulus |
Human |
— |
— |
|
DAA620 |
Hypertensive heart and renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
DAA887 |
Glomerular filtration rate declines |
Physiological |
glomerulus |
Human |
— |
— |
|
DAA880 |
Kidney mass gradually lost |
Physiological |
kidney |
Human |
— |
— |
|
DAA639 |
Kidney diseases |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|
DAA626 |
Essential (primary) hypertension and hypertensive renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
DAA890 |
IgM deposition in glomeruli |
Molecular |
glomerulus |
Human |
— |
— |
|
DAA881 |
Dietary protein required to induce renal sclerotic lesions decreases |
Physiological |
renal vasculature |
Human |
— |
— |
|